Member Info for SMISHMAN75

Better a muted start and a strong finish.
The Market will wake up soon enough.....

Antibodies (like 'Covid secure') will become a part of everyday jargon.
How many people are there in the world who will need their antibodies tested once or twice year?
7 billion?

'I suspect the current rise will be uncontainable'.

C.H.U.N.K.Y.......!

TWATCHER -
In a word. Respect.

Great list.

Please add itsallagame

Libero

You can tell FM your email has the support of a long-term holder whose entire SIPP is in BMN.

SMISHMAN

Libero -

Your email has my full support.

Nice work.

SMISH

Greetings bassguy
Tealeaves suggest JSE listing next Spring - if they are right....
SMISH

Libero -
FM has said on a number of occasions the BMN story is 'only half told.' The company's PR needs to tell the other half.
I have also pressed FM and Chika to consider a name change that includes VANADIUM in the title but the company has pushed back on this for reasons I do not understand.

Should we come to a consensus of the new name?

SMISHMAN

I have to disagree, TWatcher.
ASC and ODX have one thing in common.
Both were / are in the right place at the right time.
Arguably this applies even more to ODX.
Who would have thought NCYT could have one from 15p to the best part of a tenner in a year?
Everyone has their exit strategy.
I will not be parting with any ODX until they are (very) well north of £2.75.
Just my plan. DYOR.
SMISHMAN

To Genuine ODX holders

The first share I bought was ASC in 2004. A lucky trade. It went from 8p to 60 p in a matter of weeks. I sold, thinking I was Warren Buffet, to move onto the next multi-bagger. It did not, of course, work out that way. I had let go a diamond for the price of a piece of coal. I watched ASC creep up to £1 where it stayed for quite a while. Many sold at £1. At once stage the company warehouse burned down and the shares took a dive. But they went back up because the demand for internet shopping was just beginning. The share went, over the course of a decade, to £50 per share (you read that correctly). People kept fretting about the size of the market cap but the demand kept on mounting. It did eventually settle on the other side of the mountain, but £50 a share must be the share equivalent of Everest.

My view on ODX is that at £1 its journey is only just beginning. Like ASC the demand (here and worldwide) is going to be uncontainable. We have the gold standard test(s) and and Covid is not going away any time soon. So for genuine holders, look at the ASC experience. And for shorters and their ilk this must be the riskiest short in the market.

Just my views. DYOR.

May I add my thanks to Merchant Banker, Snowking, Mizman and others for staying positive and informative when the heat was on.

GLA

SMISH

Jay. I always read (and enjoy) your posts.
But can you use a different title for each one? Otherwise it's like reading different stories with the same title.
Hey ho....
SMISH

Hi dj -
Always been happy with them.
Aware of the merger but understand it will not affect the trading platform.
Might be worth dropping them a line?
(I am not on commission, btw!)
Just trying to help fellow ODXers - SMISH

chaps -
Try the Share Centre.
Has worked for me.
G'luck!

Hustler12

Your ignorance is deeper than the San Andreas Fault.

90 26,250 08:50
138 6,500 08:50

Just appeared.
1 mm: 6500 shares.

Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance testing, announces that it will release its financial results for the year ended 31 March 2020 on Tuesday 14 July 2020.

Omega will be hosting a live online presentation open to all investors on Wednesday 15 July at 4.30pm, delivered by Colin King, CEO. The Company is committed to providing an opportunity for all existing and potential investors to hear directly from management on its results whilst additionally providing an update on the business and current trading.

The presentation will be hosted through the digital platform Investor Meet Company. Investors can sign up to Investor Meet Company for free and add to meet Omega Diagnostics plc via the following link:
https://investormeetcompany.com/omega-diagnostics-group-plc/register-investor.

For those investors who have already registered and added to meet the Company, they will automatically be invited.

Questions can be submitted pre-event via your IMC dashboard or in real time during the presentation, via the "Ask a Question" function. Whilst the Company may not be in a position to answer every question it receives, it will address the most prominent within the confines of information already disclosed to the market through regulatory notifications. A recording of the presentation, a PDF of the slides used, and responses to the Q&A session will be available on the Investor Meet Company platform afterwards.

https://twitter.com/WalbrookPR